BRIEF published on 03/08/2024 at 13:05, 8 months 14 days ago Jolt Health Inc. Announces Strategic Expansions and Board Changes Pharmaceuticals Private Placement Financing Health And Wellness Jolt Health Inc. AI Drug Development
PRESS RELEASE published on 03/08/2024 at 13:00, 8 months 14 days ago Jolt Health Inc., Letter to the Shareholders Jolt Health Inc. focuses on health & wellness, AI drug dev., pharma sectors. Company adds Mr. Cody Corrubia to the board & announces private placement financing. Read the letter to shareholders for details Private Placement Financing Health And Wellness Jolt Health Inc. AI Drug Development Pharmaceutical Sectors
PRESS RELEASE published on 02/27/2023 at 23:10, 1 year 8 months ago Love Pharma Inc. Announces Share Consolidation
Published on 11/22/2024 at 23:55, 9 hours 8 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 33 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 9 hours 58 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 33 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 14 hours 48 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 9 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 7 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 2 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
